MYIA
TEVA icon

Mount Yale Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Mount Yale Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.33M Buy
+44,201
New +$1.42M 0.03% 457
2018
Q4 		– Sell
-11,594
Closed -$275K – 727
2018
Q3 		$275K Buy
11,594
+11,537
+20,240% +$268K 0.05% 269
2018
Q2 		$1K Buy
+57
New +$1.16K ﹤0.01% 938

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mount Yale Investment Advisors's TEVA Position: Q1 2026 in Review

Mount Yale Investment Advisors opened a new position in Teva Pharmaceuticals (TEVA) in Q1 2026: 44,201 shares worth $1.33M. The stake represents 0.03% of the portfolio and ranks #457 among its holdings. This is a return to the name: Mount Yale Investment Advisors previously reported a position in TEVA as recently as Q3 2018.

Mount Yale Investment Advisors first reported a position in TEVA in Q2 2018 and has held it in 3 quarters since. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Mount Yale Investment Advisors held 44,201 shares of Teva Pharmaceuticals worth $1.33M as of Q1 2026.
  • Teva Pharmaceuticals was a new Mount Yale Investment Advisors position in Q1 2026.
  • Teva Pharmaceuticals made up 0.03% of Mount Yale Investment Advisors's portfolio in Q1 2026, its #457 holding.
  • Mount Yale Investment Advisors first reported a position in Teva Pharmaceuticals in Q2 2018 and has held it in 3 quarters since.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Mount Yale Investment Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.